Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1089

1.

Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).

Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS.

Pediatrics. 2000 Oct;106(4):E51.

PMID:
11015546
[PubMed - indexed for MEDLINE]
2.

Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.

DuVernoy TS, Braun MM.

Pediatrics. 2000 Oct;106(4):E52.

PMID:
11015547
[PubMed - indexed for MEDLINE]
3.
4.

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.

MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Erratum in: MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(06):113.

PMID:
12825543
[PubMed - indexed for MEDLINE]
Free Article
5.

Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

[No authors listed]

MMWR Recomm Rep. 1997 Mar 28;46(RR-7):1-25. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Aug 1;46(30):706.

PMID:
9091780
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

[Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005].

van der Maas NA, David S, Kemmeren JM, Vermeer-de Bondt PE.

Ned Tijdschr Geneeskd. 2007 Dec 8;151(49):2732-7. Dutch.

PMID:
18225797
[PubMed - indexed for MEDLINE]
8.

Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.

Moro PL, Yue X, Lewis P, Haber P, Broder K.

Vaccine. 2011 Nov 21;29(50):9404-8. doi: 10.1016/j.vaccine.2011.05.100. Epub 2011 Sep 13.

PMID:
21920404
[PubMed - indexed for MEDLINE]
9.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
[PubMed - indexed for MEDLINE]
10.

The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment.

Rosenthal S, Chen R, Hadler S.

Arch Pediatr Adolesc Med. 1996 May;150(5):457-60.

PMID:
8620224
[PubMed - indexed for MEDLINE]
11.

Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.

Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S; Canadian Paediatric Society/ Health Canada Immunization Monitoring Program-Active (IMPACT).

Pediatrics. 2003 Nov;112(5):e348.

PMID:
14595075
[PubMed - indexed for MEDLINE]
12.

Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization.

Braun MM, Terracciano G, Salive ME, Blumberg DA, Vermeer-de Bondt PE, Heijbel H, Evans G, Patriarca PA, Ellenberg SS.

Pediatrics. 1998 Nov;102(5):E52.

PMID:
9794982
[PubMed - indexed for MEDLINE]
13.
14.

Clinical implications of endotoxin concentrations in vaccines.

Geier DA, Geier MR.

Ann Pharmacother. 2002 May;36(5):776-80.

PMID:
11978151
[PubMed - indexed for MEDLINE]
15.

Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.

Geier MR, Geier DA.

Exp Biol Med (Maywood). 2003 Jun;228(6):660-4.

PMID:
12773696
[PubMed - indexed for MEDLINE]
16.

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.

Pediatrics. 2006 Sep;118(3):e602-9.

PMID:
16950952
[PubMed - indexed for MEDLINE]
Free Article
17.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group.

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
[PubMed - indexed for MEDLINE]
18.

Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.

Geier D, Geier MR.

Int J Toxicol. 2004 Nov-Dec;23(6):369-76.

PMID:
15764492
[PubMed - indexed for MEDLINE]
19.

Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.

Braun MM, Ellenberg SS.

J Pediatr. 1997 Oct;131(4):529-35.

PMID:
9386653
[PubMed - indexed for MEDLINE]
20.

Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components.

Zieliński A, Rosińska M.

Przegl Epidemiol. 2008;62(3):589-96.

PMID:
19108523
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk